Elevated Plasma Levels of Antimicrobial Polypeptides in Patients with Severe Sepsis

被引:48
作者
Berkestedt, Ingrid [2 ]
Herwald, Heiko [3 ]
Ljunggren, Lennart [4 ]
Nelson, Axel [2 ]
Bodelsson, Mikael [1 ,2 ]
机构
[1] Univ Lund Hosp, Dept Anaesthesia & Intens Care, SE-22185 Lund, Sweden
[2] Lund Univ, Dept Anaesthesiol & Intens Care, Lund, Sweden
[3] Lund Univ, Dept Infect Med, Lund, Sweden
[4] Malmo Univ, Dept Biomed Lab Sci, Malmo, Sweden
基金
瑞典研究理事会;
关键词
Antimicrobial peptide; Sepsis; Bactericidal/permeability-increasing protein; Heparin-binding protein; LL-37; Defensins; BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; PEPTIDE LL-37; HUMAN CATHELICIDIN; BINDING PROTEIN; CHILDREN;
D O I
10.1159/000317036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We wanted to investigate if plasma levels of antimicrobial polypeptides (AMPs) are increased in severe sepsis and if they correlate with severity and mortality. Samples were collected from 31 sepsis patients at the intensive care unit. The Sequential Organ Failure Assessment (SOFA) score and 90-day mortality were registered, and inflammatory markers and AMP levels were measured by ELISA. A median SOFA score (13) and cardiovascular SOFA score (3) indicated multiorgan failure with severe circulatory derangement, and elevated cytokine levels indicated inflammatory activation. Levels of bactericidal/permeability-increasing protein, heparin-binding protein, alpha-defensins and lactoferrin but not LL-37 were elevated in sepsis patients compared with controls. Bactericidal/permeability-increasing protein levels correlated with mortality, with lower levels in survivors. Levels of all AMPs, except LL-37, positively correlated with the cardiovascular SOFA score. In conclusion, levels of several AMPs are increased in sepsis and correlate with circulatory derangement. This probably reflects neutrophil activation as part of an innate immune response. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:478 / 482
页数:5
相关论文
共 19 条
  • [1] Endogenous antimicrobial peptide LL-37 induces human vasodilatation
    Berkestedt, I.
    Nelson, A.
    Bodelsson, M.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2008, 100 (06) : 803 - 809
  • [2] Antibacterial peptides: basic facts and emerging concepts
    Boman, HG
    [J]. JOURNAL OF INTERNAL MEDICINE, 2003, 254 (03) : 197 - 215
  • [3] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [4] CALVANO SE, 1994, ARCH SURG-CHICAGO, V129, P220
  • [5] Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro
    Ciornei, CD
    Egesten, A
    Bodelsson, M
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2003, 47 (02) : 213 - 220
  • [6] The immunopathogenesis of sepsis
    Cohen, J
    [J]. NATURE, 2002, 420 (6917) : 885 - 891
  • [7] ANTIBIOTIC PROTEINS OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES
    GABAY, JE
    SCOTT, RW
    CAMPANELLI, D
    GRIFFITH, J
    WILDE, C
    MARRA, MN
    SEEGER, M
    NATHAN, CF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (14) : 5610 - 5614
  • [8] Heparin-binding protein (HBP/CAP37):: A missing link in neutrophil-evoked alteration of vascular permeability
    Gautam, N
    Olofsson, AM
    Herwald, H
    Iversen, LF
    Lundgren-Åkerlund, E
    Hedqvist, P
    Arfors, KE
    Flodgaard, H
    Lindbom, L
    [J]. NATURE MEDICINE, 2001, 7 (10) : 1123 - 1127
  • [9] Medical progress: The pathophysiology and treatment of sepsis.
    Hotchkiss, RS
    Karl, IE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02) : 138 - 150
  • [10] Contact-system activation in children with vasculitis
    Kahn, R
    Herwald, H
    Müller-Esterl, W
    Schmitt, R
    Sjögren, AC
    Truedsson, L
    Karpman, D
    [J]. LANCET, 2002, 360 (9332) : 535 - 541